Evidence map›Paper›PMID 28611756›Full record

ArticleFrontiers in microbiology2017

Pathogenic

Thais A Amamura, Tatiana R Fraga, Sílvio A Vasconcellos, Angela S Barbosa, Lourdes Isaac

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Complement Resistance Assays.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Screening of Surface-Exposed Lipoproteins ofFrontiers in microbiology · 2022
    Article
  12. Article
  13. Leptolysin, aFrontiers in cellular and infection microbiology · 2022
    Article
  14. In Silico Structural and Functional Characterization of HtrA Proteins ofTropical medicine and infectious disease · 2020
    Article
  15. Cytokine Profile in Early Infection byJournal of immunology research · 2019
    Article
  16. Biotechnology reports (Amsterdam, Netherlands) · 2018
    Article
  17. Article
  18. Pathology and pathogenesis of human leptospirosis: a commented review.Revista do Instituto de Medicina Tropical de Sao Paulo · 2018
    Review
  19. Frontiers in cellular and infection microbiology · 2018
    Article
  20. Role of Murine Complement Component C5 in AcuteFrontiers in cellular and infection microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Thais A AmamuraLaboratory of Complement, Department of Immunology, Institute of Biomedical Sciences, University of São PauloSão Paulo, Brazil.
Tatiana R FragaLaboratory of Complement, Department of Immunology, Institute of Biomedical Sciences, University of São PauloSão Paulo, Brazil.
Sílvio A VasconcellosFaculty of Veterinary Medicine, University of São PauloSão Paulo, Brazil.
Angela S BarbosaLaboratory of Bacteriology, Butantan InstituteSão Paulo, Brazil.
Lourdes IsaacLaboratory of Complement, Department of Immunology, Institute of Biomedical Sciences, University of São PauloSão Paulo, Brazil.
Universidade de São Paulo · BRInstituto Butantan · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leptospirosis is a zoonosis caused by spirochetes from the genus

Indexed as

complement systemimmune evasionLeptospiraMACproteases

Identifiers

PMID28611756
PMCPMC5447677
OpenAlexW2618906471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.